On 31 January 2026, the final IDEA-FAST Clinical Observation Study participant completed their last visit, marking the official end of our COS, with a total of 1,887 participants across all study sites. IDEA-FAST marks one of the largest clinical wearable sensor studies worldwide specifically focused on validating digital endpoints across multiple chronic diseases. The sensor data, together with concomitant comprehensive clinical and patient-reported outcome (PRO) data provides an invaluable bioresource for future research and innovation in a wide range of research disciplines.
Over the next few months, our consortium partners will work to conduct a preliminary analysis for a deeper understanding of our data and perform a further analysis to work towards digital endpoints.
Thank you to the IDEA-FAST clinical teams, all our participants, and partners across Europe for making this feat possible.